This inventor holds 1 USPTO granted patent. Top assignee: Dongkook Pharmaceutical Co., Ltd.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: The Innovative Contributions of Su Min Ko in Biotechnology
Introduction
Su Min Ko, an inventor based in Kyunggi-do, South Korea, has made significant strides in the field of biotechnology. With one patent to his name, he has contributed to vital advancements in the production of recombinant human parathyroid hormone, a crucial protein in medical research and therapeutic applications.
Latest Patents
Su Min Ko's patent, titled "Yeast transformant producing recombinant human parathyroid hormone and method for producing the hormone," presents novel mutant strains that effectively produce human parathyroid hormone (hPTH). These innovative strains are genetically engineered to disrupt specific genes in the yapsin family of proteases, including Yapsin 1, Yapsin 2, and Yapsin 3. By incorporating the human parathyroid hormone gene into the yeast genome, the cultured strains can secrete intact hPTH into the culture media at high yield, enhancing the efficiency of hormone production.
Career Highlights
Currently, Su Min Ko is affiliated with Dongkook Pharmaceutical Co., Ltd., where he applies his expertise in biotechnology. His work focuses on innovative approaches to improving the production processes of important therapeutic proteins. His contributions not only bolster the company's research and development but also advance the broader field of biotechnology.
Collaborations
Throughout his career, Su Min Ko has collaborated with esteemed colleagues, including Sang Ki Rhee and Hyun Ah Kana. These partnerships foster a dynamic research environment, helping to drive innovations and elevate the quality of their scientific endeavors.
Conclusion
Su Min Ko’s contributions, encapsulated in his patented innovation, underscore his commitment to advancing biotechnology. Through his work at Dongkook Pharmaceutical Co., Ltd., Ko continues to play a pivotal role in developing novel methodologies for hormone production, potentially improving therapeutic options for patients worldwide. His inventive spirit and collaborative efforts in the research community highlight the importance of dedication and innovation in the field of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile